Drug-susceptibility testing in tuberculosis: methods and reliability of results

No abstract is available for this paper.

• Publication year

  2005

• Venue

  European Respiratory Journal

• Publication date

  2005-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1183/09031936.05.00111304
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Is second-line anti-tuberculosis drug susceptibility testing reliable?

  2004cited by this paper
• Utility of an In-House Mycobacteriophage-Based Assay for Rapid Detection of Rifampin Resistance in Mycobacterium tuberculosis Clinical Isolates

  2003cited by this paper
• Use of DNA Extracts from Ziehl-Neelsen-Stained Slides for Molecular Detection of Rifampin Resistance and Spoligotyping of Mycobacterium tuberculosis

  2003cited by this paper
• Use of INNO-LIPA assay for rapid identification of mycobacteria.

  2003cited by this paper
• Multicenter Evaluation of Fully Automated BACTEC Mycobacteria Growth Indicator Tube 960 System for Susceptibility Testing of Mycobacterium tuberculosis

  2002cited by this paper
• Resazurin Microtiter Assay Plate: Simple and Inexpensive Method for Detection of Drug Resistance in Mycobacterium tuberculosis

  2002cited by this paper
• Detection of Isoniazid-Resistant Mycobacterium tuberculosis Strains by a Multiplex Allele-Specific PCR Assay Targeting katG Codon 315 Variation

  2002cited by this paper
• Detection of Rifampin-Resistant Mycobacterium tuberculosis in Sputa by Nested PCR-Linked Single-Strand Conformation Polymorphism and DNA Sequencing

  2001cited by this paper
• Detection of Rifampin Resistance inMycobacterium tuberculosis in a Single Tube with Molecular Beacons

  2001cited by this paper
• Genotypic Determination of Mycobacterium tuberculosisAntibiotic Resistance Using a Novel Mutation Detection Method, the Branch Migration Inhibition M. tuberculosis Antibiotic Resistance Test

  2000cited by this paper
• Evaluation of the MB/BacT Mycobacterium Detection System for Susceptibility Testing of Mycobacterium tuberculosis

  2000cited by this paper
• Use of Real-Time PCR and Fluorimetry for Rapid Detection of Rifampin and Isoniazid Resistance-Associated Mutations in Mycobacterium tuberculosis

  2000cited by this paper
• Multicenter Laboratory Validation of Susceptibility Testing of Mycobacterium tuberculosis against Classical Second-Line and Newer Antimicrobial Drugs by Using the Radiometric BACTEC 460 Technique and the Proportion Method with Solid Media

  1999cited by this paper
• Rapid Film-Based Determination of Antibiotic Susceptibilities ofMycobacterium tuberculosis Strains by Using a Luciferase Reporter Phage and the Bronx Box

  1999cited by this paper
• Anti-tuberculosis drug resistance in the world: The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Geneva: World Health Organization, 1997. 228pp. Price Sw. fr 25/US$22.50 (in developing countries Sw. fir 17.50). (Reference WHO/TB/97.229)

  1998cited by this paper
• Evaluation of a colorimetric assay based on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis.

  1998cited by this paper
• Detection of rifampicin and isoniazid resistances of Mycobacterium tuberculosis strains by particle counting immunoassay (PACIA).

  1997cited by this paper
• Drug Susceptibility in the Chemotherapy of Mycobacterial Infections

  1991cited by this paper
• Mode of Action, Biotransformation and Pharmacokinetics of Antituberculosis Drugs in Animals and Man

  1988cited by this paper
• Manual of clinical microbiology

  1975cited by this paper
• What is drug resistance?

  1969cited by this paper
• Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes.

  1969cited by this paper
• Comparison of methods for testing the sensitivity of Mycobacterium tuberculosis to ethionamide.

  1966influential reference

• Microbiological Diagnosis of Gastrointestinal Tuberculosis

  2022cites this paper
• The evaluation of second line drug susceptibilities and molecular epidemiological profiles of multidrug resistance Mycobacterium tuberculosis isolates isoleted from different region of Turkey

  2022cites this paper
• Rapid Identification of Drug-Resistant Tuberculosis Genes Using Direct PCR Amplification and Oxford Nanopore Technology Sequencing

  2022cites this paper
• Detection of genomic mutations in katG and rpoB genes among multidrug-resistant Mycobacterium tuberculosis isolates from Tehran, Iran

  2021cites this paper
• Label-Free Comparative Proteomics of Differentially Expressed Mycobacterium tuberculosis Protein in Rifampicin-Related Drug-Resistant Strains

  2021cites this paper
• Accuracy of an amplicon-sequencing nanopore approach to identify variants in tuberculosis drug-resistance-associated genes

  2021cites this paper
• The contribution of microfluidics to the fight against tuberculosis

  2021cites this paper
• Probes and techniques used in active and the hypoxia-based dormant state of an antitubercular drug screening assay

  2021cites this paper
• Rarity of rpoB Mutations Outside the Rifampicin Resistance-Determining Region of Mycobacterium tuberculosis Isolates from Patients Responding Poorly to First-Line Tuberculosis Regimens in Beijing, China: A Retrospective Study

  2021cites this paper
• The diagnostic impact of implementing a molecular-based algorithm to standard mycobacterial screening at a reference laboratory with an intermediate prevalence for non-respiratory samples

  2021cites this paper
• Surgical Approaches in Management of Spinal Tuberculosis

  2021cites this paper
• Development and performance of CUHAS-ROBUST application for pulmonary rifampicin-resistance tuberculosis screening in Indonesia

  2021cites this paper
• Diagnosis and treatment of multidrug-resistant tuberculosis

  2020influential citation
• Detection of Drug Resistant Mycobacterium Tuberculosis Strains Using Kit SIRE Nitratase®: a Multicenter Study

  2020cites this paper
• National and sub-national level prevalence and patterns of drug resistant pulmonary tuberculosis - a systematic review and meta-analysis of Indian studies.

  2020cites this paper
• [The treatment of tuberculosis under current conditions].

  2020cites this paper
• Molecular Diagnosis of Drug Resistance in Mycobacterium tuberculosis

  2020cites this paper
• Usefulness of Xpert MTB/RIF Ultra to Rapidly Diagnose Sputum Smear-Negative Pulmonary Tuberculosis Using Bronchial Washing Fluid

  2020cites this paper
• External quality control of phenotypic drug susceptibility testing for Mycobacterium tuberculosis in China

  2020cites this paper
• Resistance Sniffer: An online tool for prediction of drug resistance patterns of Mycobacterium tuberculosis isolates using next generation sequencing data.

  2020cites this paper
• Detecting Ethambutol Resistance in Mycobacterium tuberculosis Isolates in China: A Comparison Between Phenotypic Drug Susceptibility Testing Methods and DNA Sequencing of embAB

  2020cites this paper
• Detection of low-frequency resistance-mediating SNPs in next-generation sequencing data of Mycobacterium tuberculosis complex strains with binoSNP

  2020cites this paper
• ODELAM, rapid sequence-independent detection of drug resistance in isolates of Mycobacterium tuberculosis

  2020cites this paper
• Wild-Type MIC Distribution for Re-evaluating the Critical Concentration of Anti-TB Drugs and Pharmacodynamics Among Tuberculosis Patients From South India

  2020cites this paper
• Development of New Therapeutics to Meet the Current Challenge of Drug Resistant Tuberculosis.

  2020cites this paper
• Specific gyrA gene mutations correlate with high prevalence of discordant levofloxacin resistance in Mycobacterium tuberculosis isolates from Beijing, China.

  2020cites this paper
• Interpretation of Discordant Rifampicin Susceptibility Test Results Obtained Using GeneXpert vs Phenotypic Drug Susceptibility Testing

  2020cites this paper
• A retrospective analysis of treatment outcomes of drug-susceptible TB in Kazakhstan, 2013–2016

  2019cites this paper
• Is rifampin resistance a reliable predictive marker of multidrug-resistant tuberculosis in China: a meta-analysis of findings.

  2019cites this paper
• Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study.

  2019cites this paper
• Conventional and molecular determination of drug resistance in Mycobacterium tuberculosis and Mycobacterium bovis isolates in cattle.

  2019cites this paper
• Comprehensive Characterization of the Attenuated Double Auxotroph Mycobacterium tuberculosisΔleuDΔpanCD as an Alternative to H37Rv

  2019cites this paper
• Drug-Resistant Tuberculosis and HIV

  2019cites this paper
• rpoB Mutations Causing Discordant Rifampicin Susceptibility in Mycobacterium tuberculosis: Retrospective Analysis of Prevalence, Phenotypic, Genotypic, and Treatment Outcomes

  2019cites this paper
• Direct drug susceptibility testing of Mycobacterium tuberculosis using the proportional method: A multicenter study.

  2019cites this paper
• Significance of the Differential Peptidome in Multidrug-Resistant Tuberculosis

  2019cites this paper
• Routine surveillance for the identification of drug resistant Tuberculosis in Tanzania: A cross-sectional study of stakeholders’ perceptions

  2019cites this paper
• A rapid culture system uninfluenced by an inoculum effect increases reliability and convenience for drug susceptibility testing of Mycobacterium tuberculosis

  2018cites this paper
• Of Testing and Treatment: Implications of Implementing New Regimens for Multidrug-Resistant Tuberculosis

  2017cites this paper
• Analysis of discrepant results between the Genotype® MTBDRplus assay and an antimicrobial drug susceptibility test for isoniazid-resistant tuberculosis.

  2017cites this paper
• Fluoroquinolone Resistance Mutation Detection Is Equivalent to Culture-Based Drug Sensitivity Testing for Predicting Multidrug-Resistant Tuberculosis Treatment Outcome: A Retrospective Cohort Study

  2017cites this paper
• The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis.

  2017cites this paper
• Classical against molecular-genetic methods for susceptibility testing of antituberculotics.

  2015cites this paper
• Correlating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assay.

  2015cites this paper
• Molecular detection of rifampicin resistance in multidrug-resistant Mycobacterium tuberculosis strains from North-Eastern Romania

  2013cites this paper
• What's in a name? The future of drug-resistant tuberculosis classification.

  2013cites this paper
• Susceptibility testing to second-line drugs and ethambutol by GenoType MTBDRsl and Bactec MGIT 960 comparing with agar proportion method.

  2012cites this paper
• Evaluation of the GenoType® MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs.

  2012cites this paper
• Drug-resistant tuberculosis: pediatric guidelines.

  2011cites this paper
• WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update

  2011cites this paper
• A basis for the clinical management of complicated MDR-TB cases Ignacio Monedero and Sandya Holkar summarise best practice in the often lengthy and complex managemenet of multidrug-resistant tuberculosis

  2010cites this paper
• [Consensus document on the diagnosis, treatment and prevention of tuberculosis].

  2010cites this paper
• Determination of critical concentrations of second-line anti-tuberculosis drugs with clinical and microbiological relevance.

  2010cites this paper
• Detection of Mycobacterium tuberculosis resistance mutations to rifampin and isoniazid by real-time PCR.

  2010cites this paper
• Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.

  2009cites this paper
• [Drug resistance in tuberculosis].

  2008cites this paper
• Clinical Predictors of Drug Resistance and Mortality Among Tuberculosis Patients in a Rural South African Hospital: A Case-Control Study

  2008cites this paper
• Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Antituberculosis Drugs

  2008cites this paper
• Comparison of Anti-mycobacterial Drug Susceptibility Test Results by Institutes and Methods

  2008cites this paper
• Strategies of extensively drug-resistant TB risk management for health workers and other care givers

  2008cites this paper
• Tuberculosis, drug resistance, and HIV/AIDS: A triple threat

  2007influential citation
• Management of multidrug-resistant tuberculosis and patients in retreatment

  2005influential citation
• Treatment of Isoniazid-Resistant Pulmonary Tuberculosis

  2004cites this paper